Search

Your search keyword '"Pharmaceutical Vehicles adverse effects"' showing total 264 results

Search Constraints

Start Over You searched for: Descriptor "Pharmaceutical Vehicles adverse effects" Remove constraint Descriptor: "Pharmaceutical Vehicles adverse effects" Database MEDLINE Remove constraint Database: MEDLINE
264 results on '"Pharmaceutical Vehicles adverse effects"'

Search Results

2. Topical corticosteroid vehicle composition and implications for clinical practice.

3. Challenges in Formulating Sunscreen Products.

4. Adverse Reactions to Sunscreens.

5. Iatrogenic allergic contact dermatitis of the external ear.

6. Expanding Patch Testing Beyond the Baseline Series: Usefulness of Customized Antimicrobials, Vehicles, and Cosmetics Series.

7. Potential cross-reactivity of polysorbate 80 and cremophor: A case report.

8. Carrier oils in dermatology.

9. Two Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Foam Formulation of Halobetasol Propionate, 0.05% vs Its Vehicle in Adult Subjects With Plaque Psoriasis

10. A Review of Topical Corticosteroid Foams

11. Validation of Botanical Treatment Efficiency for Adults and Children Suffering from Mild to Moderate Atopic Dermatitis

12. A Phase 2b, Randomized, Double-Blind Vehicle Controlled, Dose Escalation Study Evaluating Clascoterone 0.1%, 0.5%, and 1% Topical Cream in Subjects With Facial Acne

13. Brinzolamide-loaded nanoemulsions: ex vivo transcorneal permeation, cell viability and ocular irritation tests.

14. Image gallery: Oleoma after self-injections of anabolic steroids.

15. Patch Testing to Propylene Glycol: The Mayo Clinic Experience.

16. Hyperosmolar metabolic acidosis in burn patients exposed to glycol based topical antimicrobials-A systematic review.

17. Polyethylene glycol as marker for nitrofurazone allergy: 20 years of experience from Turkey.

18. S2k guidelines for the use of topical preparations on the skin.

19. Well-tolerated oral cyclosporine in a case of hypersensitivity to parenteral cyclosporine in postallogeneic bone marrow transplantation.

20. Potential Interference of Oil Vehicles on Genital Tubercle Development during the Fetal Period in ICR Mice.

21. Topical Desoximetasone 0.25% Spray and Its Vehicle Have Little Potential for Irritation or Sensitization.

22. Ethanol in herbal medicinal products for children : Data from pediatric studies and pharmacovigilance programs.

23. Intolerance to cosmetics as key to the diagnosis in a patient with allergic contact dermatitis caused by propylene glycol contained in a topical medication.

24. Program for Contact Allergen Research (PPAC) - a new tool for dermatologists.

25. Microemulsions for Colorectal Cancer Treatments. General Considerations and Formulation of Methotrexate.

26. A randomised trial comparing the efficacy and safety of topical ketoprofen in Transfersome(®) gel (IDEA-033) with oral ketoprofen and drug-free ultra-deformable Sequessome™ vesicles (TDT 064) for the treatment of muscle soreness following exercise.

27. Induction of oxidative stress by Taxol® vehicle Cremophor-EL triggers production of interleukin-8 by peripheral blood mononuclear cells through the mechanism not requiring de novo synthesis of mRNA.

28. Tolerability of High-Volume Subcutaneous Injections of a Viscous Placebo Buffer: A Randomized, Crossover Study in Healthy Subjects.

29. Measurement of various respiratory dynamics parameters following acute inhalational exposure to soman vapor in conscious rats.

30. Allergic contact dermatitis from the vehicle components of topical pharmaceutical products.

31. Assessing attributes of topical vehicles for the treatment of acne, atopic dermatitis, and plaque psoriasis.

32. Evaluating tretinoin formulations in the treatment of acne.

33. Drug-free gel containing ultra-deformable phospholipid vesicles (TDT 064) as topical therapy for the treatment of pain associated with osteoarthritis: a review of clinical efficacy and safety.

34. [Excipients of mandatory declaration (EMD): a non-resolved obligation].

35. Population pharmacokinetics of dimethylacetamide in children during standard and once-daily IV busulfan administration.

36. Corn oil as a vehicle in drug development exerts a dose-dependent effect on gene expression profiles in rat thymus.

37. Effect of intratumoral injection on the biodistribution and therapeutic potential of novel chemophor EL-modified single-walled nanotube loading doxorubicin.

38. Lozenge risks.

39. A survey of knowledge, opinion and practice of dentists, pharmacists and parents in Nigeria towards the use of sugar-free medication.

40. Reduction in sodium content of local anesthetics for peripheral nerve blocks: a comparative evaluation of saline with 5% dextrose--a randomized controlled double-blind study.

41. Mechanistic studies of the effect of bile salts on rhodamine 123 uptake into RBE4 cells.

42. Evaluation of biosafety and intracellular uptake of Cremophor EL free paclitaxel elastic liposomal formulation.

43. Topical rosacea therapy: the importance of vehicles for efficacy, tolerability and compliance.

44. Rampant caries from oral transmucosal fentanyl citrate lozenge abuse.

45. Side effects of control treatment can conceal experimental data when studying stress responses to injection and psychological stress in mice.

46. Interactions between novel terpenes and main components of rat and human skin: mechanistic view for transdermal delivery of propranolol hydrochloride.

47. A novel paclitaxel microemulsion containing a reduced amount of Cremophor EL: pharmacokinetics, biodistribution, and in vivo antitumor efficacy and safety.

48. Gummy bear vitamins.

49. Prospective assessment of short-term propylene glycol tolerance in neonates.

50. Allergic contact dermatitis to propyl gallate and pentylene glycol in an emollient cream.

Catalog

Books, media, physical & digital resources